Biotech Stocks Moving On Clinical Trial News

The Nasdaq iShares Biotechnology Index (IBB) has recently been on an uptrend, touching its 52-week high off the open this morning.  The ETF rose more than 1.86% during Tuesday morning’s trading, setting the stage for several other biotech stocks to follow its lead.


Furthermore, several other ETF’s tracking the sector were on the move during this morning’s session. The Health Care SPDR (XLV) recorded new highs while the S&P Biotech ETF (XBI) and NASDAQ Biotechnology Index (NBI) opened green. Many companies are also following the recent uptrend in the sector.

Biotech Stocks that hit fresh 52-week highs on Aug. 27, 2018

Biotech stocks can make jaw dropping moves contingent on data from clinical trials, if a position is taken at the right time.  As biotech sector continues to trend higher, here are a few clinical stage biotechs to watch that have linked up with Big Pharma.

Click Here For Top Biotech Stocks To Watch Today

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s